Remodeling an existing rare disease registry to be used in regulatory context: Lessons learned and recommendations

Abstract

Disease registries have been used as an interesting source of real-world data for supporting regulatory decision-making. In fact, drug studies based on registries cover pre-approval investigation, registry randomized clinical trials, and post-authorization studies. This opportunity has been investigated particularly for rare diseases—conditions affecting a small number of individuals worldwide—that represent a peculiar scenario. Several guidelines, concepts, suggestions, and laws are already available to support the design or improvement of a rare disease registry, opening the way for implementation of a registry capable of managing regulatory purposes. The present study aims to highlight the key stages performed for remodeling the existing Registry of Multiple Osteochondromas—REM into a tool consistent with EMA observations and recommendations, as well as to lead the readers through the entire adapting, remodeling, and optimizing process. The process included a variety of procedures that can be summarized into three closely related categories: semantic interoperability, data quality, and governance. At first, we strengthened interoperability within the REM registry by integrating ontologies and standards for proper data collection, in accordance with FAIR principles. Second, to increase data quality, we added additional parameters and domains and double-checked to limit human error to a bare minimum. Finally, we established two-level governance that has increased the visibility for the scientific community and for patients and carers. In conclusion, our remodeled REM registry fits with most of the scientific community’s needs and indications, as well as the best techniques for providing real-world evidence for regulatory aspects.

Secondary peripheral chondrosarcoma in multiple osteochondromas: a retrospective single-institution case series

“…We conducted a retrospective cohort study in SPC cases diagnosed at the IRCCS Istituto Ortopedico Rizzoli from 1960 to 2019. Clinical and radiological data, treatment details and follow-up information were captured from the hospital (electronic) health records and from the Registry of Multiple Osteochondromas (Registro delle Esostosi Multiple, REM - NCT04133285) [ 20 ] and paper-based information were digitalized for the aim of the present study.…”